Stay updated on Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe site now lists revision v3.5.0 and no longer shows v3.4.3.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page. This appears to be a minor platform update with no changes to the study information.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded Revision: v3.4.2; removed the previous government funding lapse notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedNotice about government funding lapse affecting site status and a version update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check58 days agoChange DetectedA new 'Show glossary' option has been added, and the page now displays a 'Revision: v3.4.0' label. There are capitalization and wording tweaks in metadata fields, such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.1%

- Check94 days agoChange DetectedDifference1%

Stay in the know with updates to Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.